Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Bladder Cancer

Free Subscription Articles published in Eur Urol Retrieve available abstracts of 144 articles: HTML format

Single Articles

June 2008
1. DE VERE WHITE R
   Re: defining optimal therapy for muscle-invasive bladder cancer.
   Eur Urol. 2008;53:1295-6.
   PubMed     Related articles   
   
   
   May 2008
2. VAN DE POEL HG
   Editorial Comment on: Microsatellite Analysis of Voided-Urine Samples for Surveillance of Low-Grade Non-Muscle-Invasive Urothelial Carcinoma: Feasibility and Clinical Utility in a Prospective Multicenter Study (Cost-Effectiveness of Follow-Up of Urinary
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
3. VAN DER AA MN , Zwarthoff EC, Steyerberg EW, Boogaard MW, et al
   Microsatellite Analysis of Voided-Urine Samples for Surveillence of Low-Grade Non-Muscle-Invasive Urothelial Carcinoma: Feasibility and Clinical Utility in a Prospective Multicenter Study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer Trial [
   Eur Urol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   April 2008
4. HABER GP , Crouzet S, Gill IS
   Laparoscopic and Robotic Assisted Radical Cystectomy for Bladder Cancer: A Critical Analysis.
   Eur Urol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. DASGUPTA P
   Editorial comment on: Laparoscopic and Robotic Assisted Radical Cystectomy for Bladder Cancer: A Critical Analysis.
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
6. STOLZENBURG JU , Liatsikos EN
   Editorial Comment on: Laparoscopic and Robotic Assisted Radical Cystectomy for Bladder Cancer: A Critical Analysis.
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
7. NIEUWENHUIJZEN JA , de Vries RR, Bex A, van der Poel HG, et al
   Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions.
   Eur Urol. 2008;53:834-42.
   PubMed     Related articles    Abstract available
   
   
   March 2008
8. SAGALOWSKY AI
   Words of wisdom. Re: Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.
   Eur Urol. 2008;53:665-6.
   PubMed     Related articles   
   
   
   
9. JOUDI FN
   Editorial comment on: Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.
   Eur Urol. 2008;53:579.
   PubMed     Related articles   
   
   
   
10. LOTAN Y
    Editorial comment on: Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.
    Eur Urol. 2008;53:579-80.
    PubMed     Related articles   
    
    
    
11. FERNANDEZ MI , Bolenz C, Trojan L, Steidler A, et al
    Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.
    Eur Urol. 2008;53:571-8.
    PubMed     Related articles    Abstract available
    
    
    February 2008
12. VERHAEGH GW , Verkleij L, Vermeulen SH, den Heijer M, et al
    Polymorphisms in the H19 Gene and the Risk of Bladder Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. MUTO S , Kamiyama Y, Ide H, Okada H, et al
    Real-time MRI of orthotopic ileal neobladder voiding: preliminary findings.
    Eur Urol. 2008;53:363-9.
    PubMed     Related articles    Abstract available
    
    
    
14. MUTO G
    Prostate-sparing cystectomy: two sides of the moon.
    Eur Urol. 2008;53:237-9.
    PubMed     Related articles   
    
    
    
15. PETTUS JA , Al-Ahmadie H, Barocas DA, Koppie TM, et al
    Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.
    Eur Urol. 2008;53:370-5.
    PubMed     Related articles    Abstract available
    
    
    
16. PRUTHI RS , Wallen EM
    Robotic-assisted laparoscopic radical cystoprostatectomy.
    Eur Urol. 2008;53:310-22.
    PubMed     Related articles    Abstract available
    
    
    January 2008
17. VAN RHIJN BW
    Considerations on the Use of Urine Markers for Bladder Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
18. SYLVESTER RJ , Oosterlinck W, Witjes JA
    The Schedule and Duration of Intravesical Chemotherapy in Patients with Non-Muscle-Invasive Bladder Cancer: A Systematic Review of the Published Results of Randomized Clinical Trials.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. SHARIAT SF , Margulis V, Lotan Y, Montorsi F, et al
    Nomograms for Bladder Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. DENZINGER S , Fritsche HM, Otto W, Blana A, et al
    Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?
    Eur Urol. 2008;53:146-52.
    PubMed     Related articles    Abstract available
    
    
    December 2007
21. HENDRICKSEN K , Witjes WP, Idema JG, Kums JJ, et al
    Comparison of Three Schedules of Intravesical Epirubicin in Patients with Non-Muscle-Invasive Bladder Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
22. HERR HW
    Outcome of Patients Who Refuse Cystectomy after Receiving Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
23. BURGER M , van der Aa MN, van Oers JM, Brinkmann A, et al
    Prediction of Progression of Non-Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
24. MONTIRONI R , Lopez-Beltran A, Cheng L
    Editorial Comment on: Prediction of Progression of Non-Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
25. VROOMAN OP , Witjes JA
    Urinary Markers in Bladder Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. GUDJONSSON S , Isfoss BL, Hansson K, Domanski AM, et al
    The Value of the UroVysion((R)) Assay for Surveillance of Non-Muscle-Invasive Bladder Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
27. BUBENDORF L
    Editorial Comment on: The Value of the UroVysion(R) Assay for Surveillance of Non-Muscle-Invasive Bladder Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
28. PYCHA A
    Editorial Comment on: The Value of the UroVysion((R)) Assay for Surveillance of Non-Muscle-Invasive Bladder Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
29. COLOMBO R
    Words of wisdom. Re: Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy.
    Eur Urol. 2007;52:1797-8.
    PubMed     Related articles   
    
    
    
30. GROSSMAN HB
    Words of wisdom. Re: radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cases.
    Eur Urol. 2007;52:1798.
    PubMed     Related articles   
    
    
    November 2007
31. KONETY BR
    Sickness and Survival in Bladder Cancer: Is Comorbidity the Crystal Ball?
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
32. MEGWALU II , Vlahiotis A, Radwan M, Piccirillo JF, et al
    Prognostic Impact of Comorbidity in Patients with Bladder Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. THOMAS AJ , Kekre NS
    Re: Alan M. Nieder, Mark S. Soloway and Harry W. Herr. Should we abandon the FISH test? Eur Urol 2007;51:1469-71.
    Eur Urol. 2007;52:1537-8.
    PubMed     Related articles   
    
    
    
34. JAKSE G
    Editorial comment on: The use of local anesthesia with N-DO injector (physion) for transurethral resection (TUR) of bladder tumors and bladder mapping: preliminary results and cost-effectiveness analysis.
    Eur Urol. 2007;52:1412-3.
    PubMed     Related articles   
    
    
    
35. OOSTERLINCK W
    Editorial comment on: The use of local anesthesia with N-DO Injector (Physion) for transurethral resection (TUR) of bladder tumors and bladder mapping: preliminary results and cost-effectiveness analysis.
    Eur Urol. 2007;52:1411-2.
    PubMed     Related articles   
    
    
    
36. BRAUSI MA , Verrini G, De Luca G, Viola M, et al
    The use of local anesthesia with N-DO injector (Physion) for transurethral resection (TUR) of bladder tumors and bladder mapping: preliminary results and cost-effectiveness analysis.
    Eur Urol. 2007;52:1407-11.
    PubMed     Related articles    Abstract available
    
    
    October 2007
37. 
    The Motion: Seminal-Nerve Sparing Radical Cystectomy is an Efficacious and Safe Treatment for Selected Bladder Cancer Patients.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
38. SYLVESTER RJ
    Editorial Comment on: Prognostic Factors in Patients with Non-Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guerin: Multivariate Analysis of Data from Four Randomized CUETO Trials.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
39. FERNANDEZ-GOMEZ J , Solsona E, Unda M, Martinez-Pineiro L, et al
    Prognostic Factors in Patients with Non-Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guerin: Multivariate Analysis of Data from Four Randomized CUETO Trials.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
40. CAI T , Mazzoli S, Mondaini N, Bartoletti R, et al
    Re: Paula M.J. Moonen, Judith M.J.E. Bakkers, Lambertus A.L.M. Kiemenay et al. Human Papilloma Virus DNA and p53 Mutation Analysis on Bladder Washes in Relation to Clinical Outcome of Bladder Cancer. Eur Urol 2007;52:464-9.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
41. WITJES JA
    Reply to Tommaso Cai, Sandra Mazzoli, Nicola Mondaini and Riccardo Bartoletti's Letter to the Editor re: Paula M.J. Moonen, Judith M.J.E. Bakkers, Lambertus A.L.M. Kiemenay et al. Human Papilloma Virus DNA and p53 Mutation Analysis on Bladder Washes in R
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
42. BRANDAU S , Suttmann H
    Re: Salvatore Siracusano, Francesca Vita, Rita Abbate, Stefano Ciciliato, Violetta Borelli, Massimiliano Bernabei and Giuliano Zabucchi. The role of granulocytes following intravesical BCG prophylaxis. Eur Urol 2007;51:1589-99.
    Eur Urol. 2007;52:1266-7.
    PubMed     Related articles   
    
    
    
43. VON DER MAASE H
    Editorial comment on: Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.
    Eur Urol. 2007;52:1122.
    PubMed     Related articles   
    
    
    
44. KOUNO T , Ando M, Yonemori K, Matsumoto K, et al
    Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.
    Eur Urol. 2007;52:1115-22.
    PubMed     Related articles    Abstract available
    
    
    
45. FRIEDRICH MG , Pichlmeier U, Schwaibold H, Conrad S, et al
    Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guerin (BCG) in patients with non-muscle-invasive bladder carcinoma.
    Eur Urol. 2007;52:1123-29.
    PubMed     Related articles    Abstract available
    
    
    
46. BHATTA DHAR N , Kessler TM, Mills RD, Burkhard F, et al
    Nerve-sparing radical cystectomy and orthotopic bladder replacement in female patients.
    Eur Urol. 2007;52:1006-14.
    PubMed     Related articles    Abstract available
    
    
    
47. KUIJPERS KA , Heesakkers JP, Jansen CF, Schalken JA, et al
    Cadherin-11 is expressed in detrusor smooth muscle cells and myofibroblasts of normal human bladder.
    Eur Urol. 2007;52:1213-21.
    PubMed     Related articles    Abstract available
    
    
    September 2007
48. ZLOTTA AR
    When and How to Treat Superficial and Muscle-Invasive Bladder Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
49. WHELAN P
    Bladder Cancer-Contemporary Dilemmas in Its Management.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
50. DAMIANO R , Di Lorenzo G, Cantiello F, De Sio M, et al
    Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis.
    Eur Urol. 2007;52:648-57.
    PubMed     Related articles    Abstract available
    
    
    
51. NG CF , Chan SY
    Re: Hamid Mazdak, Iraj Meshki and Fatemeh Ghassami. Effect of mitomycin C on anterior urethral stricture recurrence after internal urethrotomy. Eur Urol 2007;51:1089-92.
    Eur Urol. 2007;52:930.
    PubMed     Related articles   
    
    
    
52. AYYILDIZ A , Akgul T, Nuhoglu B
    Re: Hamid Mazdak, Iraj Meshki and Fatemeh Ghassami. Effect of mitomycin C on anterior urethral stricture recurrence after internal urethrotomy. Eur Urol 2007;51:1089-92.
    Eur Urol. 2007;52:929.
    PubMed     Related articles   
    
    
    
53. PYCHA A
    FISH: a tool we really need?
    Eur Urol. 2007;52:630-2.
    PubMed     Related articles   
    
    
    
54. MONTIRONI R
    Editorial comment on: FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.
    Eur Urol. 2007;52:768.
    PubMed     Related articles   
    
    
    
55. VAN OERS JM , Wild PJ, Burger M, Denzinger S, et al
    FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.
    Eur Urol. 2007;52:760-8.
    PubMed     Related articles    Abstract available
    
    
    August 2007
56. WITJES JA , Hendricksen K
    Intravesical Pharmacotherapy for Non-Muscle-Invasive Bladder Cancer: A Critical Analysis of Currently Available Drugs, Treatment Schedules, and Long-Term Results.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
57. SCHMITZ-DRAGER BJ
    Tumorgenesis due to papillomavirus infection was first demonstrated in rabbits and cattle early last century.
    Eur Urol. 2007;52:468-9.
    PubMed     Related articles   
    
    
    
58. GSCHWEND JE
    Editorial comment on: Long-term survival after gemcitabine and cisplatin in patients with locally advanced transitional cell carcinoma of the bladder: focus on supplementary treatment strategies.
    Eur Urol. 2007;52:486-7.
    PubMed     Related articles   
    
    
    
59. ALS AB , Sengelov L, von der Maase H
    Long-term survival after gemcitabine and cisplatin in patients with locally advanced transitional cell carcinoma of the bladder: focus on supplementary treatment strategies.
    Eur Urol. 2007;52:478-86.
    PubMed     Related articles    Abstract available
    
    
    
60. SAVIC-RADOJEVIC A , Mimic-Oka J, Pljesa-Ercegovac M, Opacic M, et al
    Glutathione S-transferase-P1 expression correlates with increased antioxidant capacity in transitional cell carcinoma of the urinary bladder.
    Eur Urol. 2007;52:470-7.
    PubMed     Related articles    Abstract available
    
    
    July 2007
61. LERNER SP
    Editorial Comment on: Sentinel Lymph Node Mapping of Invasive Urinary Bladder Cancer in Animal Models Using Invisible Light.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
62. THALMANN G
    Organ Preservation for T1G3 Bladder Cancer: Is It Feasible?
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
63. SOLOWAY MS
    It Is Time to Abandon the "Superficial" in Bladder Cancer.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
64. KNAPP DW , Adams LG, Degrand AM, Niles JD, et al
    Sentinel Lymph Node Mapping of Invasive Urinary Bladder Cancer in Animal Models Using Invisible Light.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
65. ZIGEUNER R
    Editorial Comment on: Diagnosis, Risk Factors, and Outcome of Urethral Recurrences Following Radical Cystectomy for Bladder Cancer in 729 Male Patients.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
66. HUGUET J , Monllau V, Sabate S, Rodriguez-Faba O, et al
    Diagnosis, Risk Factors, and Outcome of Urethral Recurrences Following Radical Cystectomy for Bladder Cancer in 729 Male Patients.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. EHDAIE B , Theodorescu D
    Words of wisdom. Re: Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.
    Eur Urol. 2007;52:281-2.
    PubMed     Related articles   
    
    
    
68. CULINE S
    Chemotherapy for advanced transitional cell carcinoma of the urothelium: cisplatin or carboplatin?
    Eur Urol. 2007;52:9-10.
    PubMed     Related articles   
    
    
    
69. DOGLIOTTI L , Carteni G, Siena S, Bertetto O, et al
    Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial.
    Eur Urol. 2007;52:134-41.
    PubMed     Related articles    Abstract available
    
    
    June 2007
70. SYLVESTER R
    Interview with Dr Richard Sylvester: transition cell carcinoma of the bladder. Interview by Christine McKillop.
    Eur Urol. 2007;51:1748-50.
    PubMed     Related articles   
    
    
    
71. MUNTENER M , Schaeffer EM, Nielsen ME, Romero FR, et al
    Rebuttal from authors re: Peter Albers. Quality criteria of laparoscopic nephroureterectomy. Eur Urol. 2007;51:1481-2.
    Eur Urol. 2007;51:1482-4.
    PubMed     Related articles   
    
    
    
72. ALBERS P
    Quality criteria of laparoscopic nephroureterectomy.
    Eur Urol. 2007;51:1481-2.
    PubMed     Related articles   
    
    
    
73. NIEDER AM , Soloway MS, Herr HW
    Should we abandon the FISH test?
    Eur Urol. 2007;51:1469-71.
    PubMed     Related articles   
    
    
    
74. SIRACUSANO S , Vita F, Abbate R, Ciciliato S, et al
    The role of granulocytes following intravesical BCG prophylaxis.
    Eur Urol. 2007;51:1589-97.
    PubMed     Related articles    Abstract available
    
    
    
75. SCHMITZ-DRAGER BJ , Beiche B, Tirsar LA, Schmitz-Drager C, et al
    Immunocytology in the assessment of patients with asymptomatic microhaematuria.
    Eur Urol. 2007;51:1582-8.
    PubMed     Related articles    Abstract available
    
    
    May 2007
76. WITJES JA
    What is the Optimal BCG Dose in Non-Muscle-Invasive Bladder Cancer?
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
77. WHELAN P
    The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancer.
    Eur Urol. 2007;51:1436-7.
    PubMed     Related articles   
    
    
    
78. BRAUSI MA
    The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancer.
    Eur Urol. 2007;51:1435-6.
    PubMed     Related articles   
    
    
    
79. HOGLUND M
    On the origin of syn- and metachronous urothelial carcinomas.
    Eur Urol. 2007;51:1185-93.
    PubMed     Related articles    Abstract available
    
    
    April 2007
80. OJEA A , Nogueira JL, Solsona E, Flores N, et al
    A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mito
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
81. BABJUK M
    Editorial Comment on: Noninvasive Diagnosis of Bladder Cancer by Detection of Matrix Metalloproteinases (MMP-2 and MMP-9) and Their Inhibitor (TIMP-2) in Urine.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
82. COLOMBO R
    Editorial Comment on: P0 Stage at Radical Cystectomy for Bladder Cancer is Associated with Improved Outcome Independent of Traditional Clinical Risk Factors.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
83. BRAUSI M
    Editorial Comment on: P0 Stage at Radical Cystectomy for Bladder Cancer is Associated with Improved Outcome Independent of Traditional Clinical Risk Factors.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
84. KASSOUF W , Spiess PE, Brown GA, Munsell MF, et al
    P0 Stage at Radical Cystectomy for Bladder Cancer is Associated with Improved Outcome Independent of Traditional Clinical Risk Factors.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
85. EISSA S , Ali-Labib R, Swellam M, Bassiony M, et al
    Noninvasive Diagnosis of Bladder Cancer by Detection of Matrix Metalloproteinases (MMP-2 and MMP-9) and Their Inhibitor (TIMP-2) in Urine.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
86. FRIEDRICH MG
    Rebuttal from Authors re: Richard J. Sylvester. Intravesical Chemotherapy in Non-Muscle-Invasive Bladder Cancer: What Schedule and Duration of Treatment?
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
87. MESSING EM
    Re: Should we screen for bladder cancer in a high-risk population? A cost per life-year saved analysis.
    Eur Urol. 2007;51:1140.
    PubMed     Related articles   
    
    
    
88. MACLENNAN GT , Kirkali Z, Cheng L
    Histologic grading of noninvasive papillary urothelial neoplasms.
    Eur Urol. 2007;51:889-97.
    PubMed     Related articles    Abstract available
    
    
    
89. JONIAU S , Shabana W, Verlinde B, Van Poppel H, et al
    Prepubic urethrectomy during radical cystoprostatectomy.
    Eur Urol. 2007;51:915-21.
    PubMed     Related articles    Abstract available
    
    
    
90. MAFFEZZINI M , Campodonico F, Canepa G, Capponi G, et al
    Short-schedule intravesical gemcitabine with ablative intent in recurrent Ta-T1, G1-G2, low- or intermediate-risk, transitional cell carcinoma of the bladder.
    Eur Urol. 2007;51:956-61.
    PubMed     Related articles    Abstract available
    
    
    March 2007
91. CAI T , Bartoletti R
    Re: Matthew E. Nielsen, Shahrokh F. Shariat, Pierre I. Karakiewicz et al. Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy. Eur Urol 2007;51:699-708.
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
92. EVANS CP
    Editorial Comment on: Long-Term Intravesical Adjuvant Chemotherapy Further Reduces Recurrence Rate Compared with Short-Term Intravesical Chemotherapy and Short-Term Therapy with Bacillus Calmette-Guerin (BCG) in Patients with Non-Muscle-Invasive Bladd
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
93. SYLVESTER RJ
    Intravesical Chemotherapy in Non-Muscle-Invasive Bladder Cancer: What Schedule and Duration of Treatment?
    Eur Urol. 2007;.
    PubMed     Related articles   
    
    
    
94. MENGUAL L , Marin-Aguilera M, Ribal MJ, Burset M, et al
    Clinical Utility of Fluorescent in situ Hybridization for the Surveillance of Bladder Cancer Patients Treated with Bacillus Calmette-Guerin Therapy.
    Eur Urol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
95. DALBAGNI G
    Re: Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy?
    Eur Urol. 2007;51:854-5.
    PubMed     Related articles   
    
    
    
96. STENZL A
    Re: Pathologic guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature.
    Eur Urol. 2007;51:849-50.
    PubMed     Related articles   
    
    
    
97. SCHRADER M , Miller K
    Re: Udo Nagele, Markus Kuczyk, Aristotelis G. Anastasiadis, Karl-Dietrich Sievert, Jorg Seibold and Arnulf Stenzl. Radical cystectomy and orthotopic bladder replacement in females, Eur Urol 2006;50:249-257.
    Eur Urol. 2007;51:862-3.
    PubMed     Related articles   
    
    
    February 2007
98. JAKSE G
    Re: superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Eur Urol. 2007;51:570-1.
    PubMed     Related articles   
    
    
    
99. FUESSEL S , Meye A, Kraemer K, Kunze D, et al
    Synthetic nucleic acids as potential therapeutic tools for treatment of bladder carcinoma.
    Eur Urol. 2007;51:315-26.
    PubMed     Related articles    Abstract available
    
    
    
100. SCHULTZ IJ , Wester K, Straatman H, Kiemeney LA, et al
     Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinoma.
     Eur Urol. 2007;51:416-22.
     PubMed     Related articles    Abstract available
     
     
     
101. NOVOTNY V , Hakenberg OW, Wiessner D, Heberling U, et al
     Perioperative complications of radical cystectomy in a contemporary series.
     Eur Urol. 2007;51:397-401.
     PubMed     Related articles    Abstract available
     
     
     January 2007
102. BURGER M , Zaak D, Stief CG, Filbeck T, et al
     Photodynamic Diagnostics and Noninvasive Bladder Cancer: Is It Cost-Effective in Long-Term Application? A Germany-Based Cost Analysis.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
103. VAN DER POEL HG
     Cytoskeleton Fragments Unveiling Bladder Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
104. SHARIAT SF , Palapattu GS, Karakiewicz PI, Rogers CG, et al
     Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
     Eur Urol. 2007;51:152-60.
     PubMed     Related articles    Abstract available
     
     
     
105. LEBRET T , Watson RW, Molinie V, Poulain JE, et al
     HSP90 expression: a new predictive factor for BCG response in stage Ta-T1 grade 3 bladder tumours.
     Eur Urol. 2007;51:161-6.
     PubMed     Related articles    Abstract available
     
     
     
106. GERULLIS H , Kuemmel C, Popken G
     Laparoscopic cystectomy with extracorporeal-assisted urinary diversion: experience with 34 patients.
     Eur Urol. 2007;51:193-8.
     PubMed     Related articles    Abstract available
     
     
     
107. SHARIAT SF , Palapattu GS, Karakiewicz PI, Rogers CG, et al
     Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.
     Eur Urol. 2007;51:137-49.
     PubMed     Related articles    Abstract available
     
     
     December 2006
108. FERNANDEZ-GOMEZ J , Rodriguez-Martinez JJ, Barmadah SE, Garcia Rodriguez J, et al
     Urinary CYFRA 21.1 Is Not a Useful Marker for the Detection of Recurrences in the Follow-Up of Superficial Bladder Cancer.
     Eur Urol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
109. THALMANN GN
     Prognostic Markers for Bladder Cancer - Are We There Yet?
     Eur Urol. 2006;.
     PubMed     Related articles   
     
     
     
110. THUROFF JW , Alken P, Engelmann U, Riedmiller H, et al
     The Mainz pouch (mixed augmentation ileum 'n zecum) for bladder augmentation and continent urinary diversion. 1985.
     Eur Urol. 2006;50:1142-50.
     PubMed     Related articles   
     
     
     
111. STOCKLE M , Alken P, Engelmann U, Jacobi GH, et al
     Radical cystectomy--often too late? 1987.
     Eur Urol. 2006;50:1132-8.
     PubMed     Related articles   
     
     
     
112. HAUTMANN RE
     Urinary diversion highlights.
     Eur Urol. 2006;50:1139-41.
     PubMed     Related articles   
     
     
     
113. STUDER UE
     Radical cystectomy--often too late? Yes, but ...
     Eur Urol. 2006;50:1129-38.
     PubMed     Related articles   
     
     
     
114. TERRONE C , Porpiglia F, Cracco C, Tarabuzzi R, et al
     Supra-ampullar cystectomy and ileal neobladder.
     Eur Urol. 2006;50:1223-33.
     PubMed     Related articles    Abstract available
     
     
     
115. HAUTMANN RE
     Thoughts on delaying cystectomy.
     Eur Urol. 2006;50:1151-2.
     PubMed     Related articles   
     
     
     November 2006
116. MOONEN PM , Bakkers JM, Kiemeney LA, Schalken JA, et al
     Human Papilloma Virus DNA and p53 Mutation Analysis on Bladder Washes in Relation to Clinical Outcome of Bladder Cancer.
     Eur Urol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
117. NIELSEN ME , Shariat SF, Karakiewicz PI, Lotan Y, et al
     Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy.
     Eur Urol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
118. MAI KT , Park PC, Yazdi HM, Saltel E, et al
     Plasmacytoid urothelial carcinoma of the urinary bladder report of seven new cases.
     Eur Urol. 2006;50:1111-4.
     PubMed     Related articles    Abstract available
     
     
     October 2006
119. MOONEN PM , Merkx GF, Peelen P, Karthaus HF, et al
     UroVysion Compared with Cytology and Quantitative Cytology in the Surveillance of Non-Muscle-Invasive Bladder Cancer.
     Eur Urol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
120. BURGUES JP , Gomez L, Pontones JL, Vera CD, et al
     A Chemosensitivity Test for Superficial Bladder Cancer Based on Three-Dimensional Culture of Tumour Spheroids.
     Eur Urol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
121. VAN DER POEL HG
     Foreseeing cancer metastases.
     Eur Urol. 2006;50:648-9.
     PubMed     Related articles   
     
     
     September 2006
122. GUY L , Savareux L, Molinie V, Botto H, et al
     Should bladder biopsies be performed routinely after bacillus Calmette-Guerin treatment for high-risk superficial transitional cell cancer of the bladder?
     Eur Urol. 2006;50:516-20.
     PubMed     Related articles    Abstract available
     
     
     
123. YURAKH AO , Ramos D, Calabuig-Farinas S, Lopez-Guerrero JA, et al
     Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder.
     Eur Urol. 2006;50:506-15.
     PubMed     Related articles    Abstract available
     
     
     August 2006
124. TRITSCHLER S , Scharf S, Karl A, Tilki D, et al
     Validation of the Diagnostic Value of NMP22((R)) BladderChek((R)) Test as a Marker for Bladder Cancer by Photodynamic Diagnosis.
     Eur Urol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     July 2006
125. BARTSCH GC , Kuefer R, Gschwend JE, de Petriconi R, et al
     Hydronephrosis as a Prognostic Marker in Bladder Cancer in a Cystectomy-Only Series.
     Eur Urol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
126. VALE C , Stewart L, Tierney J
     Re: Emilio Bria, Enzo Maria Ruggeri, Camillo Francesco Pollera, Edmondo Terzoli, Francesco Cognetti and Diana Giannarelli. Adjuvant Chemotherapy for Bladder Cancer: The Chance for Meta-Analyses Comparisons. Eur Urol. In press.
     Eur Urol. 2006;.
     PubMed     Related articles   
     
     
     
127. SCHRIER BP , Vriesema JL, Witjes JA, Kiemeney LA, et al
     The predictive value of p53, p27(kip1), and alpha-catenin for progression in superficial bladder carcinoma.
     Eur Urol. 2006;50:76-82.
     PubMed     Related articles    Abstract available
     
     
     June 2006
128. BRIA E , Ruggeri EM, Pollera CF, Terzoli E, et al
     Adjuvant Chemotherapy for Bladder Cancer: The Chance for Meta-analyses Comparison.
     Eur Urol. 2006;.
     PubMed     Related articles   
     
     
     
129. KARAKIEWICZ PI , Shariat SF, Palapattu GS, Perrotte P, et al
     Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage.
     Eur Urol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
130. MENGUAL L , Burset M, Ars E, Ribal MJ, et al
     Partially Degraded RNA from Bladder Washing is a Suitable Sample for Studying Gene Expression Profiles in Bladder Cancer.
     Eur Urol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
131. FAHMY NM , Mahmud S, Aprikian AG
     Delay in the Surgical Treatment of Bladder Cancer and Survival: Systematic Review of the Literature.
     Eur Urol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
132. MOONEN PM , Peelen P, Kiemeney LA, Boon ME, et al
     Quantitative cytology on bladder wash versus voided urine: a comparison of results.
     Eur Urol. 2006;49:1044-9.
     PubMed     Related articles    Abstract available
     
     
     
133. AMSELLEM-OUAZANA D , Bieche I, Molinie V, Elie C, et al
     Is quantitative real-time RT-PCR an adjunct to immunohistochemistry for the evaluation of ErbB2 status in transitional carcinoma of the bladder?
     Eur Urol. 2006;49:1035-42.
     PubMed     Related articles    Abstract available
     
     
     May 2006
134. MAFFEZZINI M
     Re: Sylvester RJ, van der Meijden APM, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DWW, Kurth K. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2
     Eur Urol. 2006;.
     PubMed     Related articles   
     
     
     
135. SYLVESTER RJ
     Reply to Dr Maffezzini Letter to the Editor re: Sylvester RJ, van der Meijden APM, Oosterlinck W, J. Witjes A, Bouffioux C, Denis L, Newling DWW, Kurth K. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Usi
     Eur Urol. 2006;.
     PubMed     Related articles   
     
     
     
136. BURGER M , Burger SJ, Denzinger S, Wild PJ, et al
     Elevated Microsatellite Instability at Selected Tetranucleotide Repeats does not Correlate with Clinicopathologic Features of Bladder Cancer.
     Eur Urol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
137. PALOU REDORTA J
     Management of BCG "Failures".
     Eur Urol. 2006;49:779-80.
     PubMed     Related articles   
     
     
     
138. KASHIBUCHI K , Tomita K, Schalken JA, Kume H, et al
     The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
     Eur Urol. 2006;49:839-45.
     PubMed     Related articles    Abstract available
     
     
     March 2006
139. SHERIF A , Garske U, Torre MD, Thorn M, et al
     Hybrid SPECT-CT: An Additional Technique for Sentinel Node Detection of Patients with Invasive Bladder Cancer.
     Eur Urol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
140. AGERBAEK M , Alsner J, Marcussen N, Lundbeck F, et al
     Focal S100A4 Protein Expression Is an Independent Predictor of Development of Metastatic Disease in Cystectomized Bladder Cancer Patients.
     Eur Urol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     February 2006
141. OOSTERLINCK W
     Watchful waiting for low-grade Ta bladder tumours: the idea would have been unacceptable 30 years ago, but nowadays we are highly interested in the results of this study exploring it.
     Eur Urol. 2006;49:215-6.
     PubMed     Related articles   
     
     
     
142. GOFRIT ON , Pode D, Lazar A, Katz R, et al
     Watchful waiting policy in recurrent Ta G1 bladder tumors.
     Eur Urol. 2006;49:303-6.
     PubMed     Related articles    Abstract available
     
     
     January 2006
143. PASSEROTTI CC , Bonfim A, Martins JR, Dall'Oglio MF, et al
     Urinary hyaluronan as a marker for the presence of residual transitional cell carcinoma of the urinary bladder.
     Eur Urol. 2006;49:71-5.
     PubMed     Related articles    Abstract available
     
     
     October 2005
144. LAZZERI M , Vannucchi MG, Spinelli M, Bizzoco E, et al
     Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
     Eur Urol. 2005;48:691-8.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: